Skip to content

Tissue oxygenation and perfusion and the determination of glucose subcutaneously

Tissue oxygenation and perfusion and the determination of glucose subcutaneously - TOP DOGS

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON34018
Enrollment
60
Registered
2009-04-20
Start date
2009-07-14
Completion date
Unknown
Last updated
2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

glucose metabolism

Interventions

None listed

Sponsors

Onze Lieve Vrouwe Gasthuis
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Willing and able to give written informed consent admittance to the OLVG for elective open cardiac surgery (coronary artery bypass graft [CABG]; mitral-, tricuspidal- and aortic valve surgery) age 18-85 years

Exclusion criteria

Exclusion criteria: abdominal abnormalities that inhibit sensor insertion

Design outcomes

Primary

MeasureTime frame
Difference in glucose values (mmol/l) measured by the two CGMs, Guardian RT and FreeStyle Navigator compared to *gold standard* blood glucose values measured by the Accu-Chek Compact plus (mmol/l), expressed as mean absolute difference (MAD) of glucose values.

Secondary

MeasureTime frame
1. Microcirculatory function expressed as % of perfused vessels as measured by OPS. 2. Microcirculatory function expressed as microvascular flow index (MFI) as measured by OPS. 3. Tissue oxygen saturation (StO2) expressed as ratio oxygenated haemoglobin to total haemoglobin as measured by near infrared spectroscopy (NIRS). 4. Systemic oxygen saturation (SpO2) expressed as % as measured by pulse oximetry. 5. APACHE II score. 6. SOFA score. 7. Glucose values expressed as mmol/l as measured by the Accu-Chek Compact plus.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)